GLP-1/glucagon receptor (dual) drugs for Obesity

6 tracked GLP-1/glucagon receptor (dual) drugs in the Obesity race. The class explanation lives on the GLP-1/glucagon receptor (dual) page; the full indication pipeline across every mechanism is on the Obesity page.

2 Phase 32 Phase 21 Phase 1/21 Phase 1

Head-to-head evidence: AZD9550 vs DA-1726 · AZD9550 vs PB-718 · AZD9550 vs Zabopegdutide · AZD9550 vs mazdutide · AZD9550 vs survodutide · DA-1726 vs PB-718

The roster

← all GLP-1/glucagon receptor (dual) drugs